Shares of Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) have earned a consensus rating of "Moderate Buy" from the eleven research firms that are presently covering the stock, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $79.30.
Several research firms have recently issued reports on HSIC. Wall Street Zen lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Barrington Research lowered their price target on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 6th. Piper Sandler lowered their price target on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 30th. Finally, Wells Fargo & Company lowered their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th.
Check Out Our Latest Stock Analysis on Henry Schein
Hedge Funds Weigh In On Henry Schein
Hedge funds have recently bought and sold shares of the company. JPMorgan Chase & Co. grew its stake in Henry Schein by 6.5% in the 1st quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company's stock worth $436,489,000 after buying an additional 390,399 shares in the last quarter. Invesco Ltd. grew its stake in Henry Schein by 0.4% in the 4th quarter. Invesco Ltd. now owns 4,963,409 shares of the company's stock worth $343,468,000 after buying an additional 17,552 shares in the last quarter. FMR LLC grew its stake in Henry Schein by 6.6% in the 4th quarter. FMR LLC now owns 3,498,033 shares of the company's stock worth $242,064,000 after buying an additional 217,143 shares in the last quarter. Geode Capital Management LLC grew its stake in Henry Schein by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company's stock worth $218,762,000 after buying an additional 14,876 shares in the last quarter. Finally, Palestra Capital Management LLC purchased a new position in Henry Schein in the 4th quarter worth approximately $182,988,000. Hedge funds and other institutional investors own 96.62% of the company's stock.
Henry Schein Stock Performance
Shares of HSIC stock opened at $74.67 on Friday. The firm has a market cap of $9.09 billion, a price-to-earnings ratio of 23.33, a P/E/G ratio of 2.41 and a beta of 0.87. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.75 and a current ratio of 1.38. Henry Schein has a 52 week low of $60.56 and a 52 week high of $82.49. The firm's 50-day simple moving average is $70.70 and its two-hundred day simple moving average is $71.18.
Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.11 by $0.04. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The company's revenue for the quarter was down .1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.10 earnings per share. As a group, equities analysts forecast that Henry Schein will post 4.74 earnings per share for the current year.
About Henry Schein
(
Get Free ReportHenry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.